News About: R&D


Full support for embryo stem cells and genome research.

The Health and Medical Technology Research Planning and Review Team of the Health Industry Promotion Board announced to elect the total 17 research subjects related with bio technology fully to support, including 5 su...

Citri made successful development of Clarithromycin

Citri Co. announced on Dec. 14 that Clarithromycin, an anti-bacterial agent against Helicobacter pylori was successfully developed for the lst time in Korea and the 2nd in the world after Abbott. Its patent registrati...

POSTECH Launch to Build Largest Private BT Research Center.

The largest scaled Research Center specializing Bio Technology in Korea will have a ground breaking ceremony on 19th and is looking forward for opening in 2003. Pohang University of Science and Technology began co...

Korea, US Activate Fund Raising by Private Sector and Government for Bio-venture

The decision by Korea and the United States to activate fund raising in the private and government sectors for bio-venture is expected to be help the Korean bio-engineering venture industry significantly. The Mini...

Insurance for COX-2 Inhibitor Should Cover Aged People

An argument was raised which says insurance support for the COX-2 inhibitor should cover aged people. The Penguin Association, a Korean association for overcoming arthritis disease, held an 'Arthritis Health Semina...

Government Advances Plan to Establish Life Medical Research Institute

The government is positively considering a plan to establish a Life Medical Research Institute attached to the Health Science Technology Center within the Osong Health Medical Science Complex which was originally plan...

Cardiovascular implication risks of Vioxx comparable to other NSAIDs.

MSD's Vioxx, a COX-2 selective inhibitor NSAID, showed a comparable risk level in the cardiovascular side effects with other placebo and 4 NSAIDs according to the latest journal report of "Circulation". The journal...

Bioventure Firms File Only 27 Patent Applications in Two Years

The technology level of bio-related venture and small and medium sized companies in Korea was disclosed to be weak considering that only 27 patent applications were filed by them in a span of two years from 1999 to 20...

Spur to Establish Korea Bio Valley in United States.

It is watched in attention that research foundation for Korean Bio firms seems to be established in United States, a Mecca of world bio industry. The Federation of Korean Industries and Korea Bio Venture Associati...

PP plastic infusion solution bag developed first in Korea.

A bio-venture company, Esaeng, has succeeded in developing a non-toxic polypropylene infusion bag (commonly called "Ringer solution bag") for the first time in Korea with 2 year research, which was the 2nd event of it...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.